Recent research also suggests semaglutide GLP-1 may have additional benefits, such as reducing the risk of major cardiovascular events in those with type 2 diabetes and high cardiovascular riska promising finding for many of our patients
In this double-blind trial of 1,961 adults with a body mass index (BMI) of 30 or higher, adults on high dose 2.4 mg of weekly semaglutide (compared with the usual type 2 diabetes dose of 0.5mg or 1mg) lost an average 14.9% of baseline body weight after 68 weeks of treatment versus only 2.4% for a group on placebo and lifestyle intervention alone
Injection sites rotate systematically across the abdomen, thighs, and upper arms, preventing lipohypertrophy (injection site fat accumulation) while maintaining comfortable subcutaneous access
Gastric sleeve surgery, or sleeve gastrectomy, is a popular weight-loss surgery
A comparative study found that retatrutide produced greater absolute weight reduction (16.34 kg versus 11.82 kg) and greater percentage weight loss (23.77% versus 16.79%) when data from equivalent trial durations were analyzed side by side
White adipose tissue (WAT) is the biggest mammalian triacylglycerol (TG) storage depot